Search

everythinglearnresearchcommunity

for

Search:↓

Combination therapy, including JAK inhibitors, effectively regrows hair and reduces severity in Black children with stubborn Alopecia Areata.

L-threonate may help prevent balding by blocking a key protein.

Two drugs, ritlecitinib and brepocitinib, improved scalp hair loss condition markers.

Canakinumab's effect on COVID-19 outcomes is unclear.

Poly-L-lactic acid injections can cause hair loss and skin issues.

New compounds show promise for treating benign prostate hyperplasia with fewer side effects.

Anti-Ku antibodies are linked to unique symptoms and may involve autophagy issues.

Dock5 is important for skin healing and could help treat diabetic wounds.

SGK1 is important in cancer growth and treatment resistance, and targeting it could improve therapies.

Certain inhibitors can potentially treat prostate cancer and other hormone-dependent conditions by controlling sex hormone levels in cells.

Researchers identified promising inhibitors for the BRD4 protein, including finasteride and amentoflavone.

Platelet-rich plasma is tolerable for lichen planopilaris and doesn't worsen the condition, but its effectiveness is unclear.

Lulican™ shampoo is more effective and better tolerated than Ketoconazole for treating scalp seborrheic dermatitis.

Deferasirox combined with sorafenib reduces liver cancer risk and lessens treatment side effects.

Certain compounds, especially those with a propionic substituent, could potentially be new treatments for hair loss and similar disorders.

Ketoconazole loaded solid lipid nanoparticles can penetrate skin better than regular drug suspension and marketed product, providing slow, sustained release and improved stability.

Keratin-encapsulated liposomes effectively repair and protect UV-damaged hair.

TNFα and interleukin-1 blockers reduce skin inflammation from EGFR antibody therapy.

JAK inhibitors are effective treatments for alopecia areata.

Janus kinase inhibitors may effectively treat severe alopecia areata unresponsive to other treatments.

New compounds were made that effectively block enzymes related to prostate issues and hair loss.

New mutations in KRT83 and KRT86 are linked to the hair disorder monilethrix.

Finasteride dosages should be adjusted based on CYP3A5 genotype and liver function to avoid side effects.

Dyclonine can effectively reduce skin issues by inhibiting the TRPV3 channel.

Baricitinib is the most effective treatment for alopecia areata.

Two new compounds were found to effectively reduce hair growth in mice.

Triamcinolone acetonide therapy for hair loss may cause a skin condition called linear lichen planus.

New compounds similar to cromakalim were less effective at inhibiting insulin release but improved in solubility and one acted as a calcium entry blocker, not a potassium channel opener.

NKIRAS2 can suppress certain skin tumors but its effect on cancer varies with context and expression level.

5α-reductase inhibitors and alpha-1 adrenergic antagonists together effectively treat benign prostatic hyperplasia, with long-term benefits.